CN114601899A - 一种补肾提高机体免疫功能的药粉及其制备工艺 - Google Patents
一种补肾提高机体免疫功能的药粉及其制备工艺 Download PDFInfo
- Publication number
- CN114601899A CN114601899A CN202210369587.8A CN202210369587A CN114601899A CN 114601899 A CN114601899 A CN 114601899A CN 202210369587 A CN202210369587 A CN 202210369587A CN 114601899 A CN114601899 A CN 114601899A
- Authority
- CN
- China
- Prior art keywords
- parts
- kidney
- raw materials
- powder
- tonifying kidney
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003734 kidney Anatomy 0.000 title claims abstract description 55
- 239000000843 powder Substances 0.000 title claims abstract description 28
- 230000036039 immunity Effects 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 238000005728 strengthening Methods 0.000 claims abstract description 14
- 238000000227 grinding Methods 0.000 claims abstract description 13
- 240000005739 Eurycoma longifolia Species 0.000 claims abstract description 11
- 238000004806 packaging method and process Methods 0.000 claims abstract description 11
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 9
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 9
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 9
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 9
- 241000222336 Ganoderma Species 0.000 claims abstract description 8
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 8
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 8
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 8
- 241000096284 Gynochthodes officinalis Species 0.000 claims abstract description 7
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 7
- 210000003056 antler Anatomy 0.000 claims abstract description 7
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 6
- 241000005787 Cistanche Species 0.000 claims abstract description 6
- 241000893536 Epimedium Species 0.000 claims abstract description 6
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 6
- 235000018905 epimedium Nutrition 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 6
- 101000831205 Danio rerio Dynein axonemal assembly factor 11 Proteins 0.000 claims abstract description 5
- 102100024282 Dynein axonemal assembly factor 11 Human genes 0.000 claims abstract description 5
- 241001559542 Hippocampus hippocampus Species 0.000 claims abstract description 5
- 101000831210 Homo sapiens Dynein axonemal assembly factor 11 Proteins 0.000 claims abstract description 5
- 240000007371 Cuscuta campestris Species 0.000 claims abstract description 3
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 6
- 241001478428 Syngnathus Species 0.000 claims description 5
- 239000011812 mixed powder Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 16
- 206010016256 fatigue Diseases 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 230000006872 improvement Effects 0.000 abstract description 3
- 210000003127 knee Anatomy 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 206010067484 Adverse reaction Diseases 0.000 abstract description 2
- 208000006083 Hypokinesia Diseases 0.000 abstract description 2
- 230000006838 adverse reaction Effects 0.000 abstract description 2
- 210000003414 extremity Anatomy 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 1
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 description 12
- 229940079593 drug Drugs 0.000 description 6
- 201000001881 impotence Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 241000208340 Araliaceae Species 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 206010041497 Spermatorrhoea Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000003899 penis Anatomy 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000036299 sexual function Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 208000007984 Female Infertility Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010021928 Infertility female Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 208000019914 Mental Fatigue Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- MDKCFLQDBWCQCV-UHFFFAOYSA-N benzyl isothiocyanate Chemical compound S=C=NCC1=CC=CC=C1 MDKCFLQDBWCQCV-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 210000001320 hippocampus Anatomy 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 229930182493 triterpene saponin Natural products 0.000 description 2
- HSJPEKLVIBXMHW-UHFFFAOYSA-N 1-(4-hydroxy-3-methoxyphenyl)ethane-1,1-diol Chemical compound COC1=CC(C(C)(O)O)=CC=C1O HSJPEKLVIBXMHW-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 108060003345 Adrenergic Receptor Proteins 0.000 description 1
- 102000017910 Adrenergic receptor Human genes 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 108090000312 Calcium Channels Proteins 0.000 description 1
- 102000003922 Calcium Channels Human genes 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241001632410 Eleutherococcus senticosus Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241001633106 Lithocarpus Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- QAADZYUXQLUXFX-UHFFFAOYSA-N N-phenylmethylthioformamide Natural products S=CNCC1=CC=CC=C1 QAADZYUXQLUXFX-UHFFFAOYSA-N 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- BLGXFZZNTVWLAY-CCZXDCJGSA-N Yohimbine Natural products C1=CC=C2C(CCN3C[C@@H]4CC[C@@H](O)[C@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-CCZXDCJGSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 102000004305 alpha Adrenergic Receptors Human genes 0.000 description 1
- 108090000861 alpha Adrenergic Receptors Proteins 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- BLGXFZZNTVWLAY-UHFFFAOYSA-N beta-Yohimbin Natural products C1=CC=C2C(CCN3CC4CCC(O)C(C4CC33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000711 cavernous sinus Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000009986 erectile function Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 230000002474 noradrenergic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000003087 receptor blocking agent Substances 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- GQDDNDAYOVNZPG-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C[C]2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3N=C21 GQDDNDAYOVNZPG-SCYLSFHTSA-N 0.000 description 1
- 229960000317 yohimbine Drugs 0.000 description 1
- AADVZSXPNRLYLV-UHFFFAOYSA-N yohimbine carboxylic acid Natural products C1=CC=C2C(CCN3CC4CCC(C(C4CC33)C(O)=O)O)=C3NC2=C1 AADVZSXPNRLYLV-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种补肾提高机体免疫功能的药粉,成分包括:红参、鹿茸、灵芝、玛卡、肉苁蓉、壮阳果、海龙、海马、黄精、枸杞、菟丝子、刺五加、五味子、红花、巴戟天、东革阿里、淫羊藿、卡宾达树皮。制备工艺,包括以下步骤:1)准备原料;2)研磨搅拌;3)包装。本发明优点在于:原料清晰,制备简单,能够补肾壮阳、益气补血,对腰膝酸软、畏寒肢冷、倦怠乏力、性功能低下、易疲劳、易倦怠等临床症状有明显改善,治疗前后有明显差异,且未发现毒副作用或不良反应,疗效肯定,安全可靠,具有推广应用价值。
Description
技术领域
本发明涉及保健品技术领域,具体是指一种补肾提高机体免疫功能的药粉及其制备工艺。
背景技术
在中医理论中,肾不仅仅是一个有形的脏器,而是肾脏及与其相关的一系列功能活动的总称,如人的精神、骨骼、头发、牙齿等的病理变化都可能与肾有密切关系,其范围较西医要广。肾的精气从作用来说可分为肾阴、肾阳两方面,肾阴与肾阳相互依存、相互制约,维持人体的动态平衡。当这一平衡遭到破坏后,就会出现肾阴、肾阳偏衰或偏盛的病理变化。肾虚是肾脏精气阴阳不足所产生的诸如精神疲乏、头晕耳鸣、健忘脱发、腰脊酸痛、遗精阳痿、男子不育、女子不孕、更年期综合征等多种病证的一个综合概念。
现代人由于工作压力大、运动量少,很容易出现全身脏器功能衰退,肾虚则是其中的一种。为防止未老先衰,现代人,尤其是现代白领一族应当加强身体锻炼身体,并及时对证滋补,改善肾虚、衰老症状。随着生活水平的提高,补肾成为男性中较为流行的一种健康方式。目前男性补肾的主要方法有食用猪肾、羊肾等。补肾是男性追求自身更加强壮的方法。
中医补肾目前是国内较为常用的方法,但是随着有此类需求的男性越来越多,临床补肾的方法也成了一个新的空白。目前西医研制而成的补肾药品种较为繁多,但是其效果受到质疑,并且补肾药市场鱼龙混杂。中医各种补肾药物也层出不穷,由于肾虚有不同的情况,根据中医辨证治疗的方法进行开发的补肾药物很少,更有甚者,认为补肾就是壮阳也导致了很多药物的滥用,给人民群众的健康带来危害。
因此,一种补肾提高机体免疫功能的药粉及其制备工艺亟待研究。
发明内容
本发明的目的在于提供一种补肾提高机体免疫功能的药粉及其制备工艺,以解决上述背景技术中提出的问题。
为解决上述技术问题,本发明提供的技术方案为:一种补肾提高机体免疫功能的药粉,其包括以下重量份的成分:红参5~9份、鹿茸5~9份、灵芝5~9份、玛卡5~9份、肉苁蓉9~16份、壮阳果7~15份、海龙2~6份、海马1~6份、黄精5~9份、枸杞5~9份、菟丝子6~10份、刺五加4~9份、五味子1~5份、红花1~6份、巴戟天3~9份、东革阿里3~9份、淫羊藿3~9份、卡宾达树皮3~9份。
一种补肾提高机体免疫功能的药粉的制备工艺,具体包括以下步骤:
1)准备原料:按照比例选取符合标准的优质原料;
2)研磨搅拌:将原料研磨成粉,并按照比例混合;
3)包装:将上述混合粉末包装成所需规格。
作为一种优选方案,所述步骤2)中研磨至100目。
本发明优点在于:原料清晰,制备简单,能够补肾壮阳、益气补血,对腰膝酸软、畏寒肢冷、倦怠乏力、性功能低下、易疲劳、易倦怠等临床症状有明显改善,治疗前后有明显差异,且未发现毒副作用或不良反应,疗效肯定,安全可靠,具有推广应用价值。
具体实施方式
下面用具体实施例说明本发明,并不是对本发明的限制。
实施例1
一种补肾提高机体免疫功能的药粉,其包括以下重量份的成分:红参5份、鹿茸5份、灵芝5份、玛卡5份、肉苁蓉9份、壮阳果7份、海龙2份、海马1份、黄精9份、枸杞9份、菟丝子10份、刺五加9份、五味子5份、红花6份、巴戟天9份、东革阿里9份、淫羊藿9份、卡宾达树皮9份。
一种补肾提高机体免疫功能的药粉的制备工艺,具体包括以下步骤:
1)准备原料:按照比例选取符合标准的优质原料;
2)研磨搅拌:将原料研磨成100目粉末,并按照比例混合;
3)包装:将上述混合粉末包装成所需规格。
实施例2
一种补肾提高机体免疫功能的药粉,其包括以下重量份的成分:红参9份、鹿茸9份、灵芝9份、玛卡9份、肉苁蓉16份、壮阳果15份、海龙6份、海马6份、黄精5份、枸杞5份、菟丝子6份、刺五加4份、五味子1份、红花1份、巴戟天3份、东革阿里3份、淫羊藿3份、卡宾达树皮3份。
一种补肾提高机体免疫功能的药粉的制备工艺,具体包括以下步骤:
1)准备原料:按照比例选取符合标准的优质原料;
2)研磨搅拌:将原料研磨成100目粉末,并按照比例混合;
3)包装:将上述混合粉末包装成所需规格。
实施例3
一种补肾提高机体免疫功能的药粉,其包括以下重量份的成分:红参7份、鹿茸7份、灵芝7份、玛卡7份、肉苁蓉12份、壮阳果11份、海龙4份、海马3份、黄精7份、枸杞7份、菟丝子8份、刺五加6份、五味子3份、红花4份、巴戟天6份、东革阿里6份、淫羊藿6份、卡宾达树皮6份。
一种补肾提高机体免疫功能的药粉的制备工艺,具体包括以下步骤:
1)准备原料:按照比例选取符合标准的优质原料;
2)研磨搅拌:将原料研磨成100目粉末,并按照比例混合;
3)包装:将上述混合粉末包装成所需规格。
使用方法:将药粉用温水冲泡饮用即可,也可加入汤、茶中服用。
成分分析:
红参的主要成分是三萜皂苷,还含有挥发油、多糖、氨基酸、微量元素、多肽等。红参的三萜皂苷、多糖是其主要药理活性成分。
鹿茸中含有磷脂、糖脂、胶脂、激素、脂肪酸、氨基酸、蛋白质及钙、磷、镁、钠等成分,其中氨基酸成分占总成分的一半以上。鹿茸性温而不燥,具有振奋和提高机体功能,对全身虚弱、久病之后患者,有较好的强身作用,用于肾虚、头晕、耳聋、目暗、阳痿、滑精、宫冷不孕、羸瘦、神疲、畏寒、腰脊冷痛、筋骨痿软、崩漏带下、阴疽不敛及久病虚损等症;灵芝味甘,性平;归心、肺、肝、肾经。
灵芝味甘,性平;归心、肺、肝、肾经。用于补气安神,止咳平喘。
玛卡干根中的化学组成成份:蛋白质含量为10%以上(胡宁湖畔的玛卡品种的蛋白质含量超过14%),59%的碳水化合物;8.5%的纤维,内含丰富的锌、钙、铁、钛、铷、钾、钠、铜、锰、镁、锶、磷、碘等矿物质,并含有维生素C、B1、B2、B6、A、E、B12、B5,脂肪含量不高但其中多为不饱和脂肪酸,亚油酸和亚麻酸的含量达53%以上,天然活性成份包括生物碱、芥子油苷及其分解产物异硫氰酸苄酯、甾醇、多酚类物质等。
肉苁蓉甘酸咸,温。用于补肾,益精,润燥,滑肠。治男子阳痿,女子不孕,带下,血崩,腰膝冷痛,血枯便秘。
壮阳果,即厚鳞柯,坚果富含淀粉,可食,为男性壮阳药物。
海龙含胆甾醇-胆甾烯-3-酮,N-苯基-β-苯胺。脂溶性部分含有大量的游离脂肪酸,主要有肉蔻酸,棕榈酸和硬脂酸。咸甘,温。用于补肾壮阳。治阳痿。
海马具有提高机体免疫功能的作用,对延缓衰老具有一定的意义,有较好的抗应激能力;具有增强记忆力的作用,海马尚有对钙离子通道的抑制、抗血栓形成、性激素样等作用。主要用于阳痿不举,遗精遗尿,肾虚作喘,癥瘕积聚,跌打损伤,疔疮肿毒等。
黄精用于脾胃气虚,体倦乏力,胃阴不足,口干食少,肺虚燥咳,劳嗽咳血,精血不足,腰膝酸软,须发早白,内热消渴。
枸杞富含枸杞多糖,是一种水溶性多糖,是枸杞中最主要的活性成分,相对分子质量为68-200,成为国内外研究热点。其中又以枸杞多糖的免疫调节和抗肿瘤作用的研究最多。现已有很多研究表明枸杞多糖具有促进免疫、抗衰老、抗肿瘤、清除自由基、抗疲劳、抗辐射、保肝、生殖功能保护和改善等作用。
菟丝子补益肝肾,固精缩尿,安胎,明目,止泻;外用消风祛斑。
刺五加在中国医药学中做为药物广泛应用已有悠久的历史,具有“补中益精、坚筋骨、强志意”的作用,久服“轻身耐老”,与它药配伍亦可“进饮食、健气力、不忘事”。南北朝刘宋·雷敩著《炮炙论》记五加皮有“阳人使阴,阴人使阳”的作用。国外对人参及其近缘植物刺五加进行了较系统的研究,证明了刺五加和人参有相似的药理作用和临床疗效。
五味子用于久嗽虚喘,梦遗滑精,遗尿尿频,久泻不止,自汗盗汗,津伤口渴,内热消渴,心悸失眠。
红花用于经闭,痛经,恶露不行,症瘕痞块,胸痹心痛,瘀滞腹痛,胸胁刺痛,跌扑损伤,疮疡肿痛。
巴戟天用于阳痿遗精,宫冷不孕,月经不调,少腹冷痛,风湿痹痛,筋骨痿软等等。
东革阿里,现代药理科学研究表明,东革阿里的主要化学成分为苦木素二萜和生物碱两类化合物,其提取物除了能够发挥一定的改善男性性功能以及抗癌、抗疟疾功效外,降血糖、降血压、降高尿酸血症模型大鼠血尿酸水平、缓解肾脏组织的病理学损伤等多种药理作用,尤其是改善男性性功能方面引起了科学界的广泛关注。国际药学界专业人士认为东革阿里是迄今发现的抗ED效果最好的天然植物资源之一,效果优于育亨宾等,美国和欧洲多种植物类性保健产品也含有东革阿里成分。
淫羊藿具有抑制破骨细胞、促进成骨细胞生长、镇静、抗抑郁、增强免疫功能、保护心脑血管系统、抑菌、抗炎、抗病毒、抗氧化、抗衰老、抗肿瘤的功效。
卡宾达树皮是一种a肾上腺素能受体阻滞剂,能选择性地阻断神经节突触前a 2肾上腺素能受体,使血管平滑肌扩张,增加外周副交感神经张力,降低交感神经张力,因而扩张阴茎的动脉,增加阴茎海绵窦d血流量使阴茎充分勃起;同时卡宾达树皮中的生物碱通过中枢作用对勃起功能产生有益的作用,通过阻断中枢a 2肾上腺素分泌增加,及脑去甲肾上腺素能核中的细胞兴奋,使血浆中游离3-甲氧-4羟-苯乙二醇增加,从而使中枢感神经兴奋刺激,从而增加性欲。
以上所述,仅为本发明较佳的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,根据本发明的技术方案及其发明构思加以等同替换或改变,都应涵盖在本发明的保护范围之内。
Claims (3)
1.一种补肾提高机体免疫功能的药粉,其特征在于,其包括以下重量份的成分:红参5~9份、鹿茸5~9份、灵芝5~9份、玛卡5~9份、肉苁蓉9~16份、壮阳果7~15份、海龙2~6份、海马1~6份、黄精5~9份、枸杞5~9份、菟丝子6~10份、刺五加4~9份、五味子1~5份、红花1~6份、巴戟天3~9份、东革阿里3~9份、淫羊藿3~9份、卡宾达树皮3~9份。
2.一种补肾提高机体免疫功能的药粉的制备工艺,其特征在于,具体包括以下步骤:
1)准备原料:按照比例选取符合标准的优质原料;
2)研磨搅拌:将原料研磨成粉,并按照比例混合;
3)包装:将上述混合粉末包装成所需规格。
3.根据权利要求2所述的一种补肾提高机体免疫功能的药粉的制备工艺,其特征在于:所述步骤2)中研磨至100目。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210369587.8A CN114601899A (zh) | 2022-04-08 | 2022-04-08 | 一种补肾提高机体免疫功能的药粉及其制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210369587.8A CN114601899A (zh) | 2022-04-08 | 2022-04-08 | 一种补肾提高机体免疫功能的药粉及其制备工艺 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114601899A true CN114601899A (zh) | 2022-06-10 |
Family
ID=81868856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210369587.8A Pending CN114601899A (zh) | 2022-04-08 | 2022-04-08 | 一种补肾提高机体免疫功能的药粉及其制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114601899A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106139086A (zh) * | 2016-08-06 | 2016-11-23 | 彭婉蓉 | 一种具有散湿疏肝理气排毒补肾的调节粉 |
CN111073787A (zh) * | 2020-01-16 | 2020-04-28 | 张洪滔 | 固本培元益肾养生酒及其制备方法 |
CN113616709A (zh) * | 2021-09-02 | 2021-11-09 | 衢州市衢江区廿里镇养和残疾人之家 | 一种治疗男性不育症中药组合物及其制作工艺 |
-
2022
- 2022-04-08 CN CN202210369587.8A patent/CN114601899A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106139086A (zh) * | 2016-08-06 | 2016-11-23 | 彭婉蓉 | 一种具有散湿疏肝理气排毒补肾的调节粉 |
CN111073787A (zh) * | 2020-01-16 | 2020-04-28 | 张洪滔 | 固本培元益肾养生酒及其制备方法 |
CN113616709A (zh) * | 2021-09-02 | 2021-11-09 | 衢州市衢江区廿里镇养和残疾人之家 | 一种治疗男性不育症中药组合物及其制作工艺 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102784295B (zh) | 一种改善女性更年期综合症的保健制剂配方及其制备方法 | |
CN105232907A (zh) | 一种补肾壮阳饮料及其制备方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN107893007A (zh) | 一种具有强肾益精功效的酵素啤酒及其制备方法 | |
CN103689559A (zh) | 一种有助于改善胃肠功能的养生保健食品配方及其制备方法 | |
CN101314024A (zh) | 一种治疗艾滋病的中药胶囊 | |
CN101152359A (zh) | 一种保健药酒及其制造方法 | |
CN107156820A (zh) | 全面调理女性产后受损体质的营养食品及其制备方法 | |
CN104911086A (zh) | 一种养肝强肾的保健酒 | |
CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
CN104432052A (zh) | 一种能抗疲劳防衰老的保健胶囊及其制备方法 | |
CN114601899A (zh) | 一种补肾提高机体免疫功能的药粉及其制备工艺 | |
CN113456778A (zh) | 一种提升能量的组合物及其制备方法 | |
CN102973687B (zh) | 调节妇女内分泌平衡的口服液 | |
CN114748583A (zh) | 一种滋补养生的中药药酒 | |
CN102250736B (zh) | 一种保健药酒及其制造方法 | |
CN112245550A (zh) | 一种具有调畅情志功效的中药组合物及其制备方法 | |
CN111481600A (zh) | 补肾膏 | |
CN110584037A (zh) | 一种食品人参膏及其制备方法 | |
CN104523983A (zh) | 一种白发转黑发的药物及其制备方法 | |
CN110420313A (zh) | 一种阿胶人参饮品的生产工艺及其方法 | |
CN108310159A (zh) | 一种降血压的膏药及其制备方法 | |
CN113142429B (zh) | 一种补气血饮品组合物及其制备方法 | |
CN108310212A (zh) | 一种用于延缓衰老的药物及其制备方法和应用 | |
CN102000258A (zh) | 一种具有抗疲劳和增强免疫力作用的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220610 |
|
RJ01 | Rejection of invention patent application after publication |